Merit Medical Receives FDA "Breakthrough Device Designation" for Embosphere Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis Seite 1
07.03.2022 - SOUTH JORDAN, Utah, March 07, 2022 (GLOBE NEWSWIRE) - Merit Medical Systems, Inc. (NASDAQ: MMSI), announced today that it has received “breakthrough device designation” from the U.S. Food & Drug Administration (FDA) for Embosphere Microspheres for ... Seite 1